These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 3759918

  • 1. Appearance of mania in drug-resistant bipolar depressed patients after treatment with L-triiodothyronine.
    Evans DL, Strawn SK, Haggerty JJ, Garbutt JC, Burnett GB, Pedersen CA.
    J Clin Psychiatry; 1986 Oct; 47(10):521-2. PubMed ID: 3759918
    [Abstract] [Full Text] [Related]

  • 2. T3 augmentation of antidepressant treatment in T4-replaced thyroid patients.
    Cooke RG, Joffe RT, Levitt AJ.
    J Clin Psychiatry; 1992 Jan; 53(1):16-8. PubMed ID: 1737734
    [Abstract] [Full Text] [Related]

  • 3. The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS.
    Kelly T, Lieberman DZ.
    J Affect Disord; 2009 Aug; 116(3):222-6. PubMed ID: 19215985
    [Abstract] [Full Text] [Related]

  • 4. Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6- to 12-year-olds.
    Geller B, Fox LW, Fletcher M.
    J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):43-50. PubMed ID: 8428883
    [Abstract] [Full Text] [Related]

  • 5. Antidepressant-induced mood conversions in bipolar disorder: a retrospective study of tricyclic versus non-tricyclic antidepressant drugs.
    Koszewska I, Rybakowski JK.
    Neuropsychobiology; 2009 Jan; 59(1):12-6. PubMed ID: 19221443
    [Abstract] [Full Text] [Related]

  • 6. An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression.
    Birkenhäger TK, Vegt M, Nolen WA.
    Pharmacopsychiatry; 1997 Jan; 30(1):23-6. PubMed ID: 9065966
    [Abstract] [Full Text] [Related]

  • 7. Rational polypharmacy in the bipolar affective disorders.
    Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.
    Epilepsy Res Suppl; 1996 Jan; 11():153-80. PubMed ID: 9294735
    [Abstract] [Full Text] [Related]

  • 8. The therapeutic use of triiodothyronine and high dose thyroxine in psychiatric disorder.
    Whybrow PC.
    Acta Med Austriaca; 1994 Jan; 21(2):47-52. PubMed ID: 7998482
    [Abstract] [Full Text] [Related]

  • 9. Carbamazepine in bipolar-depressed disorder complicated by tricyclic antidepressant switching: case report.
    Nurnberg HG, Finkel JA.
    J Clin Psychiatry; 1985 Nov; 46(11):487-8. PubMed ID: 4055709
    [Abstract] [Full Text] [Related]

  • 10. Abuse of dosulepin to induce mania.
    Lepping P, Menkes DB.
    Addiction; 2007 Jul; 102(7):1166-7. PubMed ID: 17567406
    [Abstract] [Full Text] [Related]

  • 11. Charcoal enhancement of treatment for tricyclic-induced mania.
    Jain V, Swartz CM.
    Pharmacopsychiatry; 2002 Sep; 35(5):197-9. PubMed ID: 12237792
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacotherapy in depression during conversion from depression to mania in patients with bipolar affective disorder].
    Koszewska I.
    Psychiatr Pol; 1996 Sep; 30(1):113-25. PubMed ID: 8722244
    [Abstract] [Full Text] [Related]

  • 13. [Administration of thyroid hormones in therapy of psychiatric illnesses].
    Weissel M.
    Acta Med Austriaca; 1999 Sep; 26(4):129-31. PubMed ID: 10526631
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacotherapy of depression in patients with and without conversion from depression to mania in the course of bipolar affective disorder].
    Koszewska I.
    Psychiatr Pol; 1996 Sep; 30(1):99-111. PubMed ID: 8722243
    [Abstract] [Full Text] [Related]

  • 15. The use of thyroid supplements to augment antidepressant medication.
    Joffe RT.
    J Clin Psychiatry; 1998 Sep; 59 Suppl 5():26-9; discussion 30-1. PubMed ID: 9635545
    [Abstract] [Full Text] [Related]

  • 16. [Switch to mania].
    Ohgake S, Iyo M.
    Ryoikibetsu Shokogun Shirizu; 2003 Sep; (38):379-80. PubMed ID: 12877007
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of depression in bipolar disorder: new directions for research.
    Zornberg GL, Pope HG.
    J Clin Psychopharmacol; 1993 Dec; 13(6):397-408. PubMed ID: 8120153
    [Abstract] [Full Text] [Related]

  • 18. Antidepressant-induced rapid cycling: another perspective.
    Mattes JA.
    Ann Clin Psychiatry; 2006 Dec; 18(3):195-9. PubMed ID: 16923658
    [Abstract] [Full Text] [Related]

  • 19. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sänger E, Engel G, Hamm AO, Nauck M, Meng W.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [Abstract] [Full Text] [Related]

  • 20. The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder.
    Ferreira Ade A, Neves FS, da Rocha FF, Silva GS, Romano-Silva MA, Miranda DM, De Marco L, Correa H.
    J Affect Disord; 2009 Jan; 112(1-3):267-72. PubMed ID: 18534687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.